Meanwhile, DIDE could reverse the changes of these serum lipids, such as hyperglycemia and insulin resistance altered by the HFD feeding, which correlate with obesity-related metabolic disturbances that include hypertension, insulin resistance, impaired insulin secretion and cardiovascular disease [33,34]. The gene discussed is INS; the disease is Hyperglycemia.